Product logins

Find logins to all Clarivate products below.


chevron_left

Case Study: Unlocking the potential of advanced computational methods in drug discovery

Case Study: Unlocking the potential of advanced computational methods in drug discovery

Explore how a pioneering biotech company leveraged a drug combinations prediction tool to identify top-ranking drug combinations, leading to successful phase I trials.

This advanced computational approach, utilizing signatures built for proxy indications and drugs, enabled our client to identify disease targets and relevant vectors through a proprietary target-ID pipeline and customized analyses. This led to confident asset and indication prioritization decisions, which in turn led to better patient outcomes.

Related insights

The latest news, technologies, and resources from our team.

A comparison of OTC status of medicines across Europe
Revolutionizing treatment: Opsynvi and Winrevair shake up the PAH market
Drugs to Watch – Regulatory Focus – Talvey Drugs to Watch – Regulatory Focus – Talvey
Drugs to Watch – Regulatory Focus – Talvey
chevron_left
chevron_right